CDNA

Companies
NASDAQ
CareDx Inc.
Health Care
Price Chart
Overview

About CDNA

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

Market Cap
$793.8M
Volume
32.3M
Avg. Volume
23.7M
P/E Ratio
30.586206
Dividend Yield
0.00%
Employees
664.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Diagnostics & Research
Risk & Correlation Analysis
Market Correlation
1.59
High Correlation
Volatility
High (0.72)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for CDNA.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, CDNA shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$793.8M
Volume32.3M
P/E Ratio30.59
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 1, 2025

PortfolioPilot Analysis

Get AI-powered insights on how CDNA fits into your investment strategy and portfolio diversification.

Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025